PVT1 and breast carcinoma: For instance, lncRNA PVT1 has been implicated in gemcitabine resistance in breast cancer by upregulating drug efflux transporters and autophagy-related genes, thereby decreasing intracellular gemcitabine accumulation and enabling cancer cells to evade gemcitabine-induced apoptosis [66,112].